Mutsumi Takahata

Sapporo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Characteristics of progressive multifocal leukoencephalopathy in hematological malignancies, With reference to HIV-infected patients.

Characteristics of progressive multifocal leukoencephalopathy in hematological malignancies, With reference to HIV-infected patients.

Journal: International journal of hematology

Published: April 01, 2026

Real-world treatment patterns and clinical outcomes in patients with AML from 65 to 74 years unfit for first-line intensive chemotherapy in Japan.

Real-world treatment patterns and clinical outcomes in patients with AML from 65 to 74 years unfit for first-line intensive chemotherapy in Japan.

Journal: International journal of hematology

Published: November 07, 2025

Characterization of remdesivir resistance mutations in COVID-19 patients with various immunosuppressive diseases.

Characterization of remdesivir resistance mutations in COVID-19 patients with various immunosuppressive diseases.

Journal: Antiviral research

Published: April 08, 2025

Histiocytic sarcoma derived from the same origin as splenic marginal zone lymphoma revealed by exome analysis

Histiocytic sarcoma derived from the same origin as splenic marginal zone lymphoma revealed by exome analysis

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: September 04, 2024

FLT3 inhibitors and hematopoietic cell transplantation prolong survival in patients with FLT3-ITD-positive AML.

FLT3 inhibitors and hematopoietic cell transplantation prolong survival in patients with FLT3-ITD-positive AML.

Journal: Annals of hematology

Published: July 19, 2024

Clinical and molecular landscape of prolonged SARS-CoV-2 infection with resistance to remdesivir in immunocompromised patients.

Clinical and molecular landscape of prolonged SARS-CoV-2 infection with resistance to remdesivir in immunocompromised patients.

Journal: PNAS nexus

Published: June 17, 2024

Event-free survival at 36 months is a suitable endpoint for diffuse large B-cell lymphoma patients treated with immunochemotherapy: real-world evidence from the North Japan Hematology Study Group.

Event-free survival at 36 months is a suitable endpoint for diffuse large B-cell lymphoma patients treated with immunochemotherapy: real-world evidence from the North Japan Hematology Study Group.

Journal: Haematologica

Published: December 09, 2023

Prolonged shedding of viable SARS-CoV-2 in immunocompromised patients with haematological malignancies: A prospective study.

Prolonged shedding of viable SARS-CoV-2 in immunocompromised patients with haematological malignancies: A prospective study.

Journal: British journal of haematology

Published: August 09, 2023

Hb Hirosaki hemoglobinopathy initially suspected due to low oxygen saturation levels and abnormally low HbA1c levels

Hb Hirosaki hemoglobinopathy initially suspected due to low oxygen saturation levels and abnormally low HbA1c levels

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: May 10, 2019

A role for IL-34 in osteolytic disease of multiple myeloma.

A role for IL-34 in osteolytic disease of multiple myeloma.

Journal: Blood advances

Published: April 23, 2018

Disseminated fusariosis emerged from prolonged local genital infection after cord blood transplantation.

Disseminated fusariosis emerged from prolonged local genital infection after cord blood transplantation.

Journal: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy

Published: September 02, 2017

Cytogenetically Unrelated Clones in Acute Myeloid Leukemia Showing Different Responses to Chemotherapy.

Cytogenetically Unrelated Clones in Acute Myeloid Leukemia Showing Different Responses to Chemotherapy.

Journal: Case reports in hematology

Published: January 04, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026